FDA Inspection 1065419 — Dr. Nicola Curry
The FDA completed an inspection of Dr. Nicola Curry on Aug 30, 2018 in Oxford. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Oxford (United Kingdom)
Additional Details
Clinical Investigator (CI)